FDA’s McClellan Calls for More Sharing of Drug R&D Costs

FDA’s McClellan Calls for More Sharing of Drug R&D Costs The U.S. is bearing a disproportionate share of drug research and development costs for medicines used globally, FDA commissioner Mark McClellan said Thursday. He called for more equitable cost sharing and price setting. ‘If we do not find better ways to share the burden of […]


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog